EFFICACY AND SAFETY OF SYSTEMIC CHEMOTHERAPY IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES AND SEZARY SYNDROME: A RETROSPECTIVE STUDY OF 94 CASES

被引：0
|
作者：
Henao Viviana, Paredes [1 ]
Eva, Gonzalez-Barca [1 ]
Eva, Domingo [1 ]
Santiago, Mercadal [1 ]
Esmeralda, De La Banda [1 ]
Fina, Climent [1 ]
Cristina, Muniesa [1 ]
Anna, Sureda [1 ]
De Sevilla Alberto, Fernandez [1 ]
Teresa, Estrach [2 ]
Guillermo Armando, Lopez [2 ]
Octavio, Servitje [1 ]
机构：
[1] Hosp Univ Bellvitge, Ico, Lhospitalet De Llobregat, Spain
[2] Hosp Clin Barcelona, Barcelona, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-253
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [21] Integrating novel agents into the treatment of advanced mycosis fungoides and Sezary syndrome
    Khodadoust, Michael S.
    Mou, Eric
    Kim, Youn H.
    BLOOD, 2023, 141 (07) : 695 - 703
  • [22] Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sezary Syndrome
    Oka, Tomonori
    Miyagaki, Tomomitsu
    FRONTIERS IN MEDICINE, 2019, 6
  • [23] Racial disparities in mycosis fungoides/Sezary syndrome: an observational study of 296 patients
    Myskowski, Patricia
    Gandham, Ashley
    Geller, Shamir
    Dusza, Stephen
    Kupper, Thomas
    EUROPEAN JOURNAL OF CANCER, 2023, 190 : S17 - S17
  • [24] Chemotherapy provides less durable disease control in comparison to other systemic therapies in advanced-stage mycosis fungoides and Sezary syndrome
    Rooke, D. R.
    Ali, A.
    Fender, T.
    Shah, F.
    Chaganti, S.
    Burns, D.
    Stevens, A.
    Vydianath, B.
    Amel-Kashipaz, R.
    Hock, Y. Lin
    Irwin, C.
    Scarisbrick, J.
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : S45 - S45
  • [25] Cytomegalovirus seroprevalence is not higher in patients with mycosis fungoides/Sezary syndrome
    Gupta, RK
    Ramble, J
    Tong, CYW
    Whittaker, S
    MacMahon, E
    BLOOD, 2006, 107 (03) : 1241 - 1242
  • [26] Cardiac toxicity of alemtuzumab in patients with mycosis fungoides/Sezary syndrome
    Lenihan, DJ
    Alencar, AJ
    Yang, D
    Kurzrock, R
    Keating, MJ
    Duvic, M
    BLOOD, 2004, 104 (03) : 655 - 658
  • [27] Survival prediction model for patients with mycosis fungoides/Sezary syndrome
    Zhu, Linlin
    Han, Xiaoyang
    Liu, Zhiwen
    Leng, Songze
    Shan, Ningning
    Lv, Xiao
    Lu, Kang
    Hun, Shouyong
    Wu, Yinhang
    Liu, Xin
    FUTURE ONCOLOGY, 2020, 16 (31) : 2487 - 2498
  • [28] The spectrum of hair loss in patients with mycosis fungoides and Sezary syndrome
    Bi, Ming Yang
    Curry, Jonathan L.
    Christiano, Angela M.
    Hordinsky, Maria K.
    Norris, David A.
    Price, Vera H.
    Duvic, Madeleine
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (01) : 53 - 63
  • [29] Prognosis of 100 Japanese patients with mycosis fungoides and Sezary syndrome
    Suzuki, Shin-ya
    Ito, Kaoru
    Ito, Masaaki
    Kawai, Kazuhiro
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2010, 57 (01) : 37 - 43
  • [30] Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sezary syndrome: A multicentre, retrospective, real-world French study
    Beylot-Barry, M.
    Quereux, G.
    Nardin, C.
    Duval-Modeste, A. -b.
    Dereure, O.
    Dalac-Rat, S.
    Dobos, G.
    Pham-Ledard, A.
    Ram-Wolff, C.
    D'Incan, M.
    Grange, F.
    Braniste, V.
    Bagot, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, : 1777 - 1784
12345